Savvy Updates 10/14/24:  GLP-1s, Medtronic Recall, Breakthrough T1D & TCOYD, Sotagliflozin & FDA Appeal, How PBMs Work, CVS Break Up?, Non-D Above TTIR, Tidepool Loop

Savvy Updates 10/14/24: GLP-1s, Medtronic Recall, Breakthrough T1D & TCOYD, Sotagliflozin & FDA Appeal, How PBMs Work, CVS Break Up?, Non-D Above TTIR, Tidepool Loop

In this week’s issue of The Savvy Diabetic:  GLP-1s & T1D: How they work, dosing & pharmacokinetics Medtronic Recall for Reduced Battery Life Breakthrough T1D & TCOYD: Research Highlights Sotagliflozin (for CKD) & FDA Advocacy NOW! How PBMs...
Savvy Updates, 1/23/23:FDA Approves Mallya Smart Pen, T1D’s 6 Hormones, Inaccurate A1c Results, Fasting Diets, Diabetic Macular Edema, Healthcare Company Bankruptcies Up 84%

Savvy Updates, 1/23/23:FDA Approves Mallya Smart Pen, T1D’s 6 Hormones, Inaccurate A1c Results, Fasting Diets, Diabetic Macular Edema, Healthcare Company Bankruptcies Up 84%

FDA Clears Smart Injector Pen Device by Andrew Briskin for diaTribe.org, 17 January 2023.   In December 2022, the FDA cleared Mallya, a smart sensor that attaches directly to insulin pen injectors, turning a disposable pen into a smartphone-connected...
Skip to content